Medistim ASA (OSTO:MEDIO) EV-to-EBIT : 22.05 (As of May. 11, 2024)

Medistim ASA EV-to-EBIT Chart

Medistim ASA Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					37.89	49.33	57.75	27.98	27.95

Medistim ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															33.53	32.05	23.64	27.95	23.37

Competitive Comparison of Medistim ASA's EV-to-EBIT

For the Medical Devices subindustry, Medistim ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medistim ASA's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medistim ASA's EV-to-EBIT falls into.

Medistim ASA EV-to-EBIT Calculation

Medistim ASA's EV-to-EBIT for today is calculated as:

Medistim ASA's current Enterprise Value is kr3,060.7 Mil.
Medistim ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr138.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA  (OSTO:MEDIO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medistim ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Medistim ASA's Enterprise Value for the quarter that ended in Mar. 2024 was kr3,134.0 Mil.
Medistim ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr138.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medistim ASA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Medistim ASA (OSTO:MEDIO) Business Description